figshare
Browse
12885_2021_8281_MOESM1_ESM.docx (15.36 kB)

Additional file 1 of Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial

Download (15.36 kB)
journal contribution
posted on 2021-05-12, 03:33 authored by Ting Martin Ma, James M. Lamb, Maria Casado, Xiaoyan Wang, T. Vincent Basehart, Yingli Yang, Daniel Low, Ke Sheng, Nzhde Agazaryan, Nicholas G. Nickols, Minsong Cao, Michael L. Steinberg, Amar U. Kishan
Additional file 1: Table S1. Organ-At-Risk Dose Constraints.

Funding

Prostate Cancer Foundation American Society for Radiation Oncology

History

Usage metrics

    BMC Cancer

    Categories

    Keywords

    Prostate CancerStereotactic body radiotherapy (SBRT)Magnetic resonance imaging (MRI)Computed tomography (CT)Genitourinary (GU) toxicityGastrointestinal (GI) toxicity

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC